Pregnant Women Who Develop AAV May Safely Be Treated with Rituxan, Case Report Suggests
News
Pregnant women who develop ANCA-associated vasculitis (AAV) may safely receive Rituxan (rituximab) and corticosteroids, a case study suggests. However, this is the first study describing Rituxan’s use in pregnant women with ... Read more